In breast cancer, Lee reported that DRAIC was a potential oncogene and using more than 100 breast cancer cell lines they showed that DRAIC was high in luminal and basal subtypes compared to the claudin low subtype [10]. This evidence concerns the gene DRAIC and breast cancer.